Search - tctmd.com

Displaying 1 - 20 of 23

Sort: Relevancy | Date

Presentation ESC 2025

Helicobacter Pylori Screening after Acute Myocardial Infarction: The Cluster Randomized Crossover HELP-MI-SWEDEHEART Trial

Presenter: Robin Hofmann

August 31, 2025

Presentation AHA 2024

OptimiZation Of Lipid Lowering Therapies Using A Decision Support System In Patients With Acute Coronary Syndrome (ZODIAC): A Randomized Controlled Trial

Presenter: Kausik K. Ray

November 17, 2024

$Coronary Sinus Reducer for the treatment of refractory angina: a randomised, placebo-controlled trial (ORBITA-COSMIC)$

Presentation ACC 2024

Coronary Sinus Reducer for the treatment of refractory angina: a randomised, placebo-controlled trial (ORBITA-COSMIC)

Presenter: Rasha K. Al-Lamee

April 08, 2024

Presentation ACC 2023

Complete Revascularization Strategies in Patients Presenting With Acute Coronary Syndrome and Multivessel Coronary Disease

Presenter: Roberto Diletti

March 05, 2023

Presentation

Chronic Ischaemic Cardiovascular Disease (CICD) ESC Pilot Registry: 6-Month Follow-Up

January 19, 2018

Presentation iASSESS 2017

NSTEACS: Risk Stratification and Treatment

Presenter: Dmitriy N. Feldman

August 30, 2017

Presentation ESC 2017

Undertreatment of Female Patients in Lipid-Lowering for Secondary Prevention in Europe, Canada, South Africa, Middle East and China

Presenter: Anselm K. Gitt

August 30, 2017

Presentation ESC 2017

Clinical Efficacy and Safety of Achieving Very Low LDL-C Levels With the PCSK9 Inhibitor Evolocumab in the FOURIER Outcomes Trial

Presenter: Robert Giugliano

August 28, 2017

Presentation ESC 2017

Anti-Inflammatory Therapy with Canakinumab for Atherosclerotic Disease

Presenter: Paul M. Ridker

August 27, 2017

Presentation ESC 2017

Rivaroxaban With or Without Aspirin in Stable Cardiovascular Disease

Presenter: John Eikelboom

August 27, 2017

Presentation ESC 2017

Impact of BMI on Clinical Outcomes and Readmissions After Cardiac Catheterization

Presenter: Afnan Tariq

August 26, 2017

Presentation

Comparative Efficacy and Safety of Reperfusion Therapy With Fibrinolytic Agents in STEMI Patients

August 18, 2017

Presentation

Association Between CKD and Outcomes With Use of Prasugrel vs Clopidogrel in PCI for ACS

August 04, 2017

Presentation

Beyond Restenosis: Patients’ Preference for Drug-Eluting or Bare-Metal Stents

February 13, 2017

Presentation CCVVC 2016

Optimal Duration of DAPT: Update on DAPT Guidelines

Presenter: Roxana Mehran

June 16, 2016

Presentation SOLACI 2016

Adjunctive Pharmacology for Patients with ACS Treated Invasively

Presenter: Eric R. Bates

June 09, 2016

Presentation

Impact of Proton Pump Inhibitors (PPIs) on GI Bleeding Associated With Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) in Post-MI Patients Taking Antithrombotics

Presenter: Schjerning Olsen

October 28, 2015

Presentation

Association of Discharge Aspirin Dose With Outcomes After Acute MI

Presenter: Ying Xian

May 27, 2015

Presentation CADECI 2015

Uso responsable de Rivaroxabán en prevención secundaria después de un SCA:Casos clínicos_

Presenter: DR. JOSE LUIS LEIVA PONS

February 20, 2015

Presentation

Nuisance Bleeding with Prolonged Dual Antiplatelet Therapy After AMI and Its Impact on Health Status

Presenter: A. P. Amin

March 26, 2013

Advertisement

Helicobacter Pylori Screening after Acute Myocardial Infarction: The Cluster Randomized Crossover HELP-MI-SWEDEHEART Trial

OptimiZation Of Lipid Lowering Therapies Using A Decision Support System In Patients With Acute Coronary Syndrome (ZODIAC): A Randomized Controlled Trial

Coronary Sinus Reducer for the treatment of refractory angina: a randomised, placebo-controlled trial (ORBITA-COSMIC)

Complete Revascularization Strategies in Patients Presenting With Acute Coronary Syndrome and Multivessel Coronary Disease

Chronic Ischaemic Cardiovascular Disease (CICD) ESC Pilot Registry: 6-Month Follow-Up

NSTEACS: Risk Stratification and Treatment

Undertreatment of Female Patients in Lipid-Lowering for Secondary Prevention in Europe, Canada, South Africa, Middle East and China

Clinical Efficacy and Safety of Achieving Very Low LDL-C Levels With the PCSK9 Inhibitor Evolocumab in the FOURIER Outcomes Trial

Anti-Inflammatory Therapy with Canakinumab for Atherosclerotic Disease

Rivaroxaban With or Without Aspirin in Stable Cardiovascular Disease

Impact of BMI on Clinical Outcomes and Readmissions After Cardiac Catheterization

Comparative Efficacy and Safety of Reperfusion Therapy With Fibrinolytic Agents in STEMI Patients

Association Between CKD and Outcomes With Use of Prasugrel vs Clopidogrel in PCI for ACS

Beyond Restenosis: Patients’ Preference for Drug-Eluting or Bare-Metal Stents

Optimal Duration of DAPT: Update on DAPT Guidelines

Adjunctive Pharmacology for Patients with ACS Treated Invasively

Impact of Proton Pump Inhibitors (PPIs) on GI Bleeding Associated With Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) in Post-MI Patients Taking Antithrombotics

Association of Discharge Aspirin Dose With Outcomes After Acute MI

Uso responsable de Rivaroxabán en prevención secundaria después de un SCA:Casos clínicos_

Nuisance Bleeding with Prolonged Dual Antiplatelet Therapy After AMI and Its Impact on Health Status

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content